1,097
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma

, &
Pages 913-917 | Received 23 Aug 2005, Published online: 08 Jul 2009

References

  • Cancer Incidence in Sweden. Epidemiologiskt Centrum 2003; www.sos.se.
  • Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma. Acta Oncol 2003; 42: 605–19
  • Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in Hodgkin's lymphoma. Acta Oncol 2003; 42: 589–604
  • Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485–92
  • Hejna M, Haberl I, Raderer M. Nonsurgical management of malignant thymoma. Cancer 1999; 85: 1871–84
  • Whooley BP, Urschel JD, Antkowiak JG, Takita H. A 25-year thymoma treatment review. J Exp Clin Cancer Res 2000; 19: 3–5
  • Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ, Jr. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 1974; 34: 389–96
  • Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G, et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer 1986; 58: 765–76
  • Strander H, Turesson I, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 2003; 42: 516–31
  • Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003; 42: 387–410
  • Talbäck M, Stenbeck M, Rosén M, Glimelius B. Cancer survival in Sweden. Acta Oncol 2003; 42: 637–59
  • Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484–94
  • Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465–75
  • Travis L. Therapy-associated secondary solid cancer. Acta Oncol 2002; 41: 323–33
  • Lee YK, Cook G, Flower MA, Rowbottom C, Shahidi M, Sharma B, et al. Addition of (18)F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Radiother Oncol 2004; 73: 277–83
  • Goodman KA, Toner S, Hunt M, Wu EJ, Yahalom J. Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 2005; 62: 198–206
  • Schmidt-Wolf IG, Rockstroh JK, Schuller H, Hirner A, Grohe C, Muller-Hermelink HK, et al. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol 2003; 82: 69–76
  • Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990; 19: 273–80
  • Uematsu M, Kondo M. A proposal for treatment of invasive thymoma. Cancer 1986; 58: 1979–84
  • Uematsu M, Yoshida H, Kondo M, Itami J, Hatano K, Isobe K, et al. Entire hemithorax irradiation following complete resection in patients with stage II–III invasive thymoma. Int J Radiat Oncol Biol Phys 1996; 35: 357–60
  • Mornex F, Resbeut M, Richaud P, Jung GM, Mirabel X, Marchal C, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 1995; 32: 651–9
  • Yorke ED, Jackson A, Rosenzweig KE, Merrick SA, Gabrys D, Venkatraman ES, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002; 54: 329–39
  • Applefeld MM, Slawson RG, Hall-Craigs M, Green DC, Singleton RT, Wiernik PH. Delayed pericardial disease after radiotherapy. Am J Cardiol 1981; 47: 210–3
  • Veeragandham RS, Goldin MD. Surgical management of radiation-induced heart disease. Ann Thorac Surg 1998; 65: 1014–9
  • Knight CJ, Sutton GC. Complete heart block and severe tricuspid regurgitation after radiotherapy. Case report and review of the literature. Chest 1995; 108: 1748–51
  • McEniery PT, Dorosti K, Schiavone WA, Pedrick TJ, Sheldon WC. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol 1987; 60: 1020–4
  • Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 1989; 70: 13–7
  • Austin-Seymour M, Munzenrider J, Linggood R, Goitein M, Verhey L, Urie M, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 1990; 13: 327–30
  • Austin-Seymour M, Urie M, Munzenrider J. Considerations in fractionated proton radiation therapy: clinical potential and results. Radiother Oncol 1990; 17: 29–35
  • Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst 1992; 84: 155–64
  • Slater JM, Slater JD, Archambeau JO. Proton therapy for cranial base tumors. J Craniofac Surg 1995; 6: 24–6
  • Suit H. Regaud Lecture, Granada 1994. Tumors of the connective and supporting tissues. Radiother Oncol 1995; 34: 93–104
  • Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2003; 56: 473–81
  • Hug EB, Fitzek MM, Liebsch NJ, Munzenrider JE. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1995; 31: 467–76
  • Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys 2000; 47: 979–84
  • Isacsson U, Hagberg H, Johansson KA, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997; 45: 63–70
  • Weber DC, Trofimov AV, Delaney TF, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys 2004; 58: 1596–606
  • Miralbell R, Cella L, Weber D, Lomax A. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys 2000; 47: 1111–9
  • Smith AR, Loeffler JS, Adams JA, Lomax AJ, Niemierko A. The potential for proton therapy to improve clinical outcomes: Comparisons of proton and x-ray treatment plans for the purpose of tumor dose escalation and/or reduction of treatment-related morbidity. Int J Radiat Oncol Biol Phys 2000; 48((Suppl))338, (abstr 2150)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.